申请人:Schering Aktiengesellschaft
公开号:US05401748A1
公开(公告)日:1995-03-28
2,14-Disubstituted ergolines of formula I ##STR1## in which R, R.sup.2, R.sup.6, R.sup.14 and X have the meaning named in the application, as well as their production and use in pharmaceutical agents, are described.
本文描述了公式I的2,14-二取代的埃高啉化合物,其中R,R.sup.2,R.sup.6,R.sup.14和X的含义如申请书所述,以及它们在制备药物中的应用。